Nuveen Asset Management

Nuveen Asset Management Portfolio holdings

AUM $354B
1-Year Return 34.48%
 

Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.

This Quarter Return
-14.96%
1 Year Return
+34.48%
3 Year Return
+60.43%
5 Year Return
+189.89%
10 Year Return
+390.34%
AUM
$259B
AUM Growth
-$50.1B
Cap. Flow
-$2.37B
Cap. Flow %
-0.92%
Top 10 Hldgs %
21.65%
Holding
3,565
New
266
Increased
1,459
Reduced
1,410
Closed
322

Top Sells

1
BIDU icon
Baidu
BIDU
$302M
2
CSCO icon
Cisco
CSCO
$286M
3
ABBV icon
AbbVie
ABBV
$261M
4
NVDA icon
NVIDIA
NVDA
$210M
5
GM icon
General Motors
GM
$210M

Sector Composition

1 Technology 23.58%
2 Healthcare 13.98%
3 Financials 12.35%
4 Consumer Discretionary 10.53%
5 Industrials 8.28%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
AQB icon
3401
AquaBounty Technologies
AQB
$4.54M
-26,344
Closed -$1.13M
RRGB icon
3402
Red Robin
RRGB
$111M
-49,965
Closed -$875K
CARM icon
3403
Carisma Therapeutics
CARM
$16.8M
-26,322
Closed -$3.11M
ACTG icon
3404
Acacia Research
ACTG
$318M
-190,314
Closed -$715K
ADN icon
3405
Advent Technologies
ADN
$8.92M
-1,345
Closed -$120K
ADVM icon
3406
Adverum Biotechnologies
ADVM
$73.9M
-34,312
Closed -$3.49M
AFRM icon
3407
Affirm
AFRM
$28.4B
$0 ﹤0.01%
+334,014
New
AGS
3408
DELISTED
PlayAGS
AGS
-273,518
Closed -$2.03M
ALDX icon
3409
Aldeyra Therapeutics
ALDX
$334M
-237,359
Closed -$1.14M
ALGS icon
3410
Aligos Therapeutics
ALGS
$78.8M
-2,410
Closed -$172K
ALLK
3411
DELISTED
Allakos
ALLK
-104,701
Closed -$8.52M
AMSC icon
3412
American Superconductor
AMSC
$2.21B
-108,469
Closed -$950K
ANNX icon
3413
Annexon
ANNX
$238M
-166,803
Closed -$570K
APLT icon
3414
Applied Therapeutics
APLT
$68.2M
-53,840
Closed -$98K
APYX icon
3415
Apyx Medical
APYX
$74.1M
-85,991
Closed -$616K
ARAY icon
3416
Accuray
ARAY
$170M
-585,573
Closed -$1.92M
ARDX icon
3417
Ardelyx
ARDX
$1.57B
-256,144
Closed -$1.92M
ATOS icon
3418
Atossa Therapeutics
ATOS
$102M
-2,027,349
Closed -$3.18M
AVTX icon
3419
Avalo Therapeutics
AVTX
$153M
-141
Closed -$294K
AXDX
3420
DELISTED
Accelerate Diagnostics
AXDX
-25,549
Closed -$476K
BCAB icon
3421
BioAtla
BCAB
$31.5M
-104,744
Closed -$572K
BDSX icon
3422
Biodesix
BDSX
$64.7M
-19,512
Closed -$39K
BDTX icon
3423
Black Diamond Therapeutics
BDTX
$167M
-86,043
Closed -$268K
BEEM icon
3424
Beam Global
BEEM
$44.7M
-34,015
Closed -$511K
BMEA icon
3425
Biomea Fusion
BMEA
$114M
-39,622
Closed -$219K